Alembic rose 2.31% to Rs 48.80 at 9:55 IST on BSE after consolidated net profit rose 22% to Rs 30.24 crore on 18.8% increase in net sales to Rs 32.92 crore in Q4 March 2017 over Q4 March 2016.
The result was announced after market hours yesterday, 9 May 2017.
Meanwhile, the S&P BSE Sensex was up 172.91 points, or 0.58% at 30,106.16. The S&P BSE Small-cap index was up 112.92 points, 0.73% at 15,657.55.
On the BSE, 1.76 lakh shares were traded on the counter so far as against the average daily volumes of 3.99 lakh shares in the past one quarter. The stock had hit a high of Rs 49.70 and a low of Rs 48.50 so far during the day.
The stock had hit a 52-week high of Rs 51.65 on 24 April 2017 and a 52-week low of Rs 32.40 on 22 November 2016. The stock had outperformed the market over the past one month till 9 May 2017, advancing 21.37% compared with the Sensex's 0.76% rise. The scrip had also outperformed the market over the past one quarter advancing 26.53% as against the Sensex's 5.66% rise.
The small-cap company has equity capital of Rs 53.41 crore. Face value per share is Rs 2.
Alembic is engaged in manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
